JP2022517842A5 - - Google Patents
Info
- Publication number
- JP2022517842A5 JP2022517842A5 JP2021542307A JP2021542307A JP2022517842A5 JP 2022517842 A5 JP2022517842 A5 JP 2022517842A5 JP 2021542307 A JP2021542307 A JP 2021542307A JP 2021542307 A JP2021542307 A JP 2021542307A JP 2022517842 A5 JP2022517842 A5 JP 2022517842A5
- Authority
- JP
- Japan
- Prior art keywords
- transformation
- approximately
- diffraction pattern
- manufacturing
- cukα
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024074242A JP2024099797A (ja) | 2019-01-23 | 2024-05-01 | ７－シクロペンチル－２－（５－ピペラジン－１－イル－ピリジン－２－イルアミノ）－７Ｈ－ピロロ［２，３－ｄ］ピリミジン－６－カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962795799P | 2019-01-23 | 2019-01-23 | |
| US62/795,799 | 2019-01-23 | ||
| PCT/IB2020/050544 WO2020152629A1 (en) | 2019-01-23 | 2020-01-23 | New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024074242A Division JP2024099797A (ja) | 2019-01-23 | 2024-05-01 | ７－シクロペンチル－２－（５－ピペラジン－１－イル－ピリジン－２－イルアミノ）－７Ｈ－ピロロ［２，３－ｄ］ピリミジン－６－カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022517842A JP2022517842A (ja) | 2022-03-10 |
| JP2022517842A5 true JP2022517842A5 (https=) | 2023-02-01 |
Family
ID=69467591
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542307A Pending JP2022517842A (ja) | 2019-01-23 | 2020-01-23 | ７－シクロペンチル－２－（５－ピペラジン－１－イル－ピリジン－２－イルアミノ）－７Ｈ－ピロロ［２，３－ｄ］ピリミジン－６－カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 |
| JP2024074242A Pending JP2024099797A (ja) | 2019-01-23 | 2024-05-01 | ７－シクロペンチル－２－（５－ピペラジン－１－イル－ピリジン－２－イルアミノ）－７Ｈ－ピロロ［２，３－ｄ］ピリミジン－６－カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024074242A Pending JP2024099797A (ja) | 2019-01-23 | 2024-05-01 | ７－シクロペンチル－２－（５－ピペラジン－１－イル－ピリジン－２－イルアミノ）－７Ｈ－ピロロ［２，３－ｄ］ピリミジン－６－カルボン酸ジメチルアミドのコハク酸塩の新規な結晶形態 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12390468B2 (https=) |
| EP (1) | EP3914353A1 (https=) |
| JP (2) | JP2022517842A (https=) |
| KR (1) | KR20210119444A (https=) |
| CN (1) | CN113316471A (https=) |
| AU (2) | AU2020211071A1 (https=) |
| CA (1) | CA3124015A1 (https=) |
| IL (1) | IL284510B2 (https=) |
| WO (1) | WO2020152629A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20240026T1 (hr) | 2017-08-25 | 2024-03-29 | Assia Chemical Industries Ltd | Kruti oblik ribociklib sukcinata |
| US12390468B2 (en) | 2019-01-23 | 2025-08-19 | Novartis Ag | Crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide |
| EP4626890A1 (en) | 2022-12-01 | 2025-10-08 | KRKA, d.d., Novo mesto | Ribociclib salts and formulations thereof |
| WO2025041004A1 (en) * | 2023-08-18 | 2025-02-27 | Alembic Pharmaceuticals Limited | Polymorph of ribociclib salt |
| WO2025144118A1 (en) * | 2023-12-27 | 2025-07-03 | Deva Holding | Novel polymorph of ribociclib dihydrochloride dihydrate and method of preparation |
| TW202602868A (zh) | 2024-04-15 | 2026-01-16 | 瑞士商諾華公司 | 瑞波西利的藥物組成物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI992711A1 (it) | 1999-12-27 | 2001-06-27 | Novartis Ag | Composti organici |
| EA012926B1 (ru) | 2001-12-20 | 2010-02-26 | Оси Фармасьютикалз, Инк. | Пирролопиримидиновые соединения, относящиеся к a-селективным антагонистам, их синтез и применение |
| WO2005023761A2 (en) | 2003-09-11 | 2005-03-17 | Kemia, Inc. | Cytokine inhibitors |
| EP1781647A2 (en) | 2004-07-22 | 2007-05-09 | Astex Therapeutics Limited | Thiazole and isothiazole derivatives as protein kinase inhibitors |
| RU2468988C2 (ru) | 2005-07-22 | 2012-12-10 | Квалкомм Инкорпорэйтэд | Устройства мэмс, имеющие поддерживающие структуры, и способы их изготовления |
| AU2006331765A1 (en) | 2005-12-22 | 2007-07-05 | Wyeth | Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3(2H)-isoquinolones and use thereof as kinase inhibitor |
| TWI398252B (zh) | 2006-05-26 | 2013-06-11 | 諾華公司 | 吡咯并嘧啶化合物及其用途 |
| ES2522346T3 (es) | 2008-08-22 | 2014-11-14 | Novartis Ag | Compuestos de pirrolopirimidina como inhibidores de CDK |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| US20120115878A1 (en) | 2010-11-10 | 2012-05-10 | John Vincent Calienni | Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof |
| TWI555737B (zh) | 2011-05-24 | 2016-11-01 | 拜耳知識產權公司 | 含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺 |
| EP2818007B1 (en) | 2012-02-24 | 2022-02-23 | Nokia Technologies Oy | Method and apparatus for establishing a connection with an access network based upon access network interworking information |
| CN105111215B (zh) * | 2014-12-12 | 2019-06-18 | 苏州晶云药物科技股份有限公司 | 一种周期蛋白依赖性激酶抑制剂的晶型及其制备方法 |
| US10138250B2 (en) * | 2014-12-12 | 2018-11-27 | Crystal Pharmatech Co., Ltd. | Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt |
| US9994579B2 (en) * | 2014-12-12 | 2018-06-12 | Crystal Pharmatech Co., Ltd. | Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt |
| EP3279201B1 (en) | 2015-04-01 | 2019-10-23 | Crystal Pharmatech Co., Ltd. | Cdk inhibitor, eutectic crystal of mek inhibitor, and preparation method therefor |
| HRP20240026T1 (hr) | 2017-08-25 | 2024-03-29 | Assia Chemical Industries Ltd | Kruti oblik ribociklib sukcinata |
| WO2019111160A1 (en) * | 2017-12-04 | 2019-06-13 | Sun Pharmaceutical Industries Limited | Crystalline forms of ribociclib succinate |
| US11111250B2 (en) * | 2017-12-22 | 2021-09-07 | Shilpa Meicare Limited | Polymorphs of Ribociclib mono succinate |
| US11414421B2 (en) | 2018-01-20 | 2022-08-16 | Natco Pharma Ltd | Process for the preparation of ribociclib succinate and its novel crystalline forms thereof |
| TWI675662B (zh) | 2018-05-17 | 2019-11-01 | 中化合成生技股份有限公司 | 瑞博西尼琥珀酸鹽（Ｒｉｂｏｃｉｃｌｉｂ ｓｕｃｃｉｎａｔｅ ｓａｌｔ）晶型Ｂ、Ｃ及Ｄ與其衍生物，以及其等之製造方法與藥物組合物 |
| US12390468B2 (en) | 2019-01-23 | 2025-08-19 | Novartis Ag | Crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide |
-
2020
- 2020-01-23 US US17/424,690 patent/US12390468B2/en active Active
- 2020-01-23 KR KR1020217026158A patent/KR20210119444A/ko active Pending
- 2020-01-23 CA CA3124015A patent/CA3124015A1/en active Pending
- 2020-01-23 WO PCT/IB2020/050544 patent/WO2020152629A1/en not_active Ceased
- 2020-01-23 CN CN202080009222.3A patent/CN113316471A/zh active Pending
- 2020-01-23 IL IL284510A patent/IL284510B2/en unknown
- 2020-01-23 AU AU2020211071A patent/AU2020211071A1/en not_active Abandoned
- 2020-01-23 JP JP2021542307A patent/JP2022517842A/ja active Pending
- 2020-01-23 EP EP20703523.9A patent/EP3914353A1/en active Pending
-
2023
- 2023-02-10 AU AU2023200724A patent/AU2023200724B2/en active Active
-
2024
- 2024-05-01 JP JP2024074242A patent/JP2024099797A/ja active Pending
- 2024-11-26 US US18/960,021 patent/US20250281492A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022517842A5 (https=) | ||
| TWI670270B (zh) | 包含jak抑制劑之醫藥組合物 | |
| JP5684192B2 (ja) | トリアゾロ［４，５−ｄ］ピリミジン化合物の新規な結晶形及び非晶形 | |
| US20090247532A1 (en) | Crystalline polymorph of sitagliptin phosphate and its preparation | |
| JP2022530441A (ja) | ７ｈ－ピロロ［２，３－ｄ］ピリミジンｊａｋ－阻害剤 | |
| AU2023200724B2 (en) | New crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine -6-carboxylic acid dimethylamide | |
| TW200827356A (en) | Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile | |
| CN101253176B (zh) | 哒嗪并[4，5-b]吲哚衍生物的新晶形 | |
| JP2026041824A (ja) | テガビビントの結晶形態、調製方法、及びその使用 | |
| JP7168447B2 (ja) | ビラスチンの結晶形態及びそれらの調製方法 | |
| CN104098570A (zh) | 替卡格雷晶型及其制备方法和用途 | |
| CN114057823B (zh) | 白桦脂酸衍生物，其制备方法、药物组合物和应用 | |
| JP2004504390A (ja) | （ｒ）−ｎ−［５−メチル−８−（４−メチルピペラジン−１−イル）−１，２，３，４−テトラヒドロ−２−ナフチル］−４−モルホリノベンズアミドの新規な形態 | |
| TWI751220B (zh) | 一種ＧｎＲＨ受體拮抗劑的多晶型及其製備方法 | |
| EP1844017A1 (en) | An amorphous and three crystalline forms of rimonabant hydrochloride | |
| WO2012055163A1 (zh) | 来曲唑i型结晶及其制备方法 | |
| JP2019500371A (ja) | 置換アミノピラン誘導体の結晶形 | |
| RU2021124673A (ru) | Новые кристаллические формы сукцинатной соли диметиламида 7-циклопентил-2-(5-пиперазин-1-илпиридин-2-иламино)-7h-пирроло[2,3-d]пиримидин-6-карбоновой кислоты | |
| TWI902254B (zh) | 化合物8-氯-3-戊基-3,7-二氫-1h-嘌呤-2,6-二酮的晶型及其製備方法 | |
| WO2024179463A1 (zh) | 化合物8-氯-3-戊基-3,7-二氢-1h-嘌呤-2,6-二酮的晶型及其制备方法 | |
| WO2025203051A1 (en) | Ribociclib succinate form c and process thereof | |
| JP2001518088A (ja) | 抗不整脈薬として有用なニトロベンズアミド | |
| JP2024544772A (ja) | Ｒｅｔ阻害剤であるセルペルカチニブの結晶形態ａの調製方法 | |
| TWI330082B (en) | Crystalline form of triazolo(4,5-d)pyrimidine compound and method of preparing the same | |
| WO2025045072A1 (zh) | 一种酞嗪酮类化合物及其制备方法、药物组合物及用途 |